In summary, our results showed that serum chemerin levels significantly elevated in NSCLC patients compared with the controls, and there was a strong association between high serum chemerin levels and TNM stages, lymph node metastasis, and distant metastasis. Here, RARRES2 is linked to metastatic malignant neoplasm in the lymph nodes.